-+ 0.00%
-+ 0.00%
-+ 0.00%

Passage Bio Q4 EPS $(4.09) Misses $(2.68) Estimate

Benzinga·03/03/2026 12:21:26
Listen to the news
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(4.09) per share which missed the analyst consensus estimate of $(2.68) by 52.5 percent. This is a 2.25 percent decrease over losses of $(4.00) per share from the same period last year.